webinar register page

Webinar banner
Drawing Investment
Ireland competes for mobile global investment in the biopharmaceutical industry against strong competition. But changes in the operating environment, including in tax and in intellectual property (IP) incentives, mean the outlook is less predictable than it was. The EU’s recent Pharmaceutical Strategy is an ambitious blueprint for our industry - but, in many ways, it falls well short of advancing policies that will protect IP, especially for the development of medicines for rare diseases and for children. We examine how Ireland can continue to draw foreign direct investments - and we ask whether policymaking in Europe needs to be rebalanced in favour of patient-centred innovation.

Presented by Jonathan McCrea.

Contributors
Barry Andrews MEP
Rory Mullen, Head of BioPharma and Food, IDA Ireland
Elizabeth Kuiper, Executive Director, Public Affairs, EFPIA

Powered by Uniphar Group.

Feb 25, 2021 12:00 PM in Dublin

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Amy Brophy.